AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $924,000 | +11.1% | 61,094 | -44.9% | 0.00% | 0.0% |
Q2 2022 | $832,000 | -9.1% | 110,912 | +10.3% | 0.00% | 0.0% |
Q1 2022 | $915,000 | +15.1% | 100,513 | -11.2% | 0.00% | 0.0% |
Q4 2021 | $795,000 | -39.0% | 113,244 | -1.0% | 0.00% | 0.0% |
Q3 2021 | $1,304,000 | -32.6% | 114,349 | -5.3% | 0.00% | -50.0% |
Q2 2021 | $1,934,000 | -9.4% | 120,790 | +1.1% | 0.00% | 0.0% |
Q1 2021 | $2,135,000 | +183.5% | 119,450 | +114.3% | 0.00% | +100.0% |
Q4 2020 | $753,000 | +106.3% | 55,733 | +79.8% | 0.00% | – |
Q3 2020 | $365,000 | -20.3% | 31,000 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $458,000 | -10.5% | 31,000 | -18.2% | 0.00% | 0.0% |
Q1 2020 | $512,000 | -44.1% | 37,900 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $916,000 | +10.1% | 37,900 | -12.5% | 0.00% | 0.0% |
Q3 2019 | $832,000 | -35.0% | 43,300 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $1,280,000 | -55.8% | 43,300 | -29.0% | 0.00% | -50.0% |
Q1 2019 | $2,897,000 | +129.9% | 60,985 | +74.7% | 0.00% | +100.0% |
Q4 2018 | $1,260,000 | -48.3% | 34,900 | -11.9% | 0.00% | -33.3% |
Q3 2018 | $2,437,000 | -8.9% | 39,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $2,675,000 | +33.3% | 39,600 | +7.0% | 0.00% | +50.0% |
Q1 2018 | $2,007,000 | -4.6% | 37,000 | +5.1% | 0.00% | -33.3% |
Q4 2017 | $2,103,000 | +14.9% | 35,200 | -6.5% | 0.00% | +50.0% |
Q3 2017 | $1,830,000 | -30.7% | 37,651 | -25.0% | 0.00% | -33.3% |
Q2 2017 | $2,639,000 | +40.6% | 50,224 | +21.4% | 0.00% | 0.0% |
Q1 2017 | $1,877,000 | +47.8% | 41,386 | +23.3% | 0.00% | +50.0% |
Q4 2016 | $1,270,000 | +0.2% | 33,560 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,267,000 | +121.1% | 33,560 | +3.1% | 0.00% | +100.0% |
Q2 2016 | $573,000 | +64.7% | 32,547 | +13.6% | 0.00% | 0.0% |
Q1 2016 | $348,000 | -50.1% | 28,647 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $698,000 | +45.7% | 28,647 | +6.0% | 0.00% | 0.0% |
Q3 2015 | $479,000 | +54.0% | 27,020 | +53.1% | 0.00% | – |
Q2 2015 | $311,000 | – | 17,648 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |